ACADIA Pharmaceuticals Inc.
ACAD
$15.31
-$0.81-5.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 469.50% | 186.36% | 127.58% | 98.83% | 71.62% |
| Total Depreciation and Amortization | 186.08% | 179.43% | 259.55% | 450.31% | 174.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -263.47% | 35.88% | 18.96% | 7.68% | -12.31% |
| Change in Net Operating Assets | -77.09% | -246.66% | -179.34% | -113.16% | -52.27% |
| Cash from Operations | 844.31% | 319.07% | 334.68% | 214.51% | 114.65% |
| Capital Expenditure | -946.00% | -40.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -650.83% | -1,144.34% | -794.35% | -229.83% | -56.24% |
| Cash from Investing | -195.44% | -1,148.40% | -795.58% | -229.87% | -56.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.76% | -51.62% | 157.69% | 243.23% | 206.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -72.76% | -51.62% | 157.69% | 243.23% | 206.49% |
| Foreign Exchange rate Adjustments | -422.22% | -228.57% | -300.00% | -650.00% | -400.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.45% | 205.84% | 326.26% | -200.20% | 326.49% |
